Acrux heads to the Finnish

By Dylan Bushell-Embling
Thursday, 14 August, 2008

Acrux [ASX: ACR] has entered into a manufacturing alliance with the Finnish Orion Corporation.

Under the agreement, Orion will become the exclusive manufacturer for Acrux's Testosterone MD-Lotion, as well as a range of transdermal spray products under development.

Acrux retains the rights to supply the products to licensees in all territories.

Both parties will invest in additional equipment at Orion's manufacturing facility as part of the alliance.

Related News

Diabetes changes the structure of our hearts, study finds

Type 2 diabetes directly alters the heart's structure and energy systems, which explains why...

Beta blockers could halt triple negative breast cancer

Researchers have identified a molecular biomarker in triple negative breast cancer tumours which...

Common arthritis drug also lowers blood pressure

Scientists have known for a while that methotrexate helps with inflammation, but it may also help...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd